🇺🇸 FDA
Patent

US 7666674

Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo

granted A61KA61K2039/55555A61K2039/55561

Quick answer

US patent 7666674 (Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2039/55555, A61K2039/55561, A61K39/39, A61K9/1272